4,981
Views
33
CrossRef citations to date
0
Altmetric
Special Report

Multifaceted Role of Clay Minerals in Pharmaceuticals

, , &
Article: FSO6 | Published online: 20 Mar 2015

References

  • Grim RE . Clay minerals. Encylopedia Britannica. http://www.britannica.com/EBchecked/topic/120723/clay-mineral.
  • Zhang W , DingY, BoydSA, TeppenBJ, LiH. Sorption and desorption of carbamazepine from water by smectite clays. Chemosphere81, 954–960 (2010).
  • Carretero MI , PozoM. Clay and non-clay minerals in the pharmaceutical industry: Part I. Excipients and medical applications. Appl. Clay Sci.46, 73–80 (2009).
  • Guggenheim S , AdamsJM, BainDCet al. Summary of recommendations of nomenclature committees relevant to clay mineralogy: report of the Association Internationale pour l'Etude des Argiles (AIPEA) Nomenclature Committee for 2006. Clay Minerals41, 863–877 (2006).
  • Murray HH . Applied Clay Mineralogy – Occurrences, Processing and Application of Kaolins, Bentonites, Palygorskite-Sepiolite, and Common Clays. 141–145 (2006). In: Developments In Clay Science. (Volume 2). BergayaF, ThengBKG, LagalyG ( Eds), Elsevier, The Netherlands.
  • Sposito G , SkipperNT, SuttonR, ParkSH, SoperAK, GreathouseJA. Surface geochemistry of the clay minerals. Proc. Natl Acad. Sci. USA96, 3358–3364 (1999).
  • Liu H , ShenT, LiT, YuanP, ShiG, BaoX. Green synthesis of zeolites from a natural aluminosilicate mineral rectorite: effects of thermal treatment temperature. Appl. Clay Sci.90, 53–60 (2014).
  • Viseras C , Lopez-GalindoA. Pharmaceutical applications of some spanish clays _sepiolite, palygorskite, bentonite/: some preformulation studies. Appl. Clay Sci.14, 69–82 (1999).
  • Konta J . Clay and man: clay raw materials in the service of man. Appl. Clay Sci.10, 275–335 (1995).
  • Kim YK , LimSJ, HanMH, ChoJY. Sorption characteristics of oxytetracycline, amoxicillin, and sulfathiazole in two different soil types. Geoderma185, 97–101 (2012).
  • Bui TX , ChoiH. Influence of ionic strength, anions, cations, and natural organic matter on the adsorption of pharmaceuticals to silica. Chemosphere80, 681–686 (2010).
  • Wu LM , ZhouCH, KeelingJ, TongDS, YuWH. Towards an understanding of the role of clay minerals in crude oil formation, migration and accumulation. Earth Sci. Rev.115, 373–386 (2012).
  • Zhaohui L , ChangPH, JiangWT, JeanJS, HongH, LiaoL. Removal of diphenhydramine from water by swelling clay minerals. J. Colloid Interface Sci.360, 227–232 (2011).
  • Duarte-Silva R , Villa-GarcíaMA, RenduelesM, DíazM. Structural, textural and protein adsorption properties of kaolinite and surface modified kaolinite adsorbents. Appl. Clay Sci.90, 73–80 (2014).
  • Zhang Q , ZhangT, HeT, ChenL. Removal of crystal voilet by clay/PNIP Am nanocomposite hydrogels with various clay contents. Appl. Clay Sci.90, 1–5 (2014).
  • Ballav N , ChoiHJ, MishraSB, MaityA. Polypyrrole-coated halloysite nanotube clay nanocomposite: synthesis, characterization and Cr (VI) adsorption behaviour. Appl. Clay Sci.102, 60–70 (2014).
  • Wang YC , HuangTK, TungSH, WuTM, LinJJ. Self-assembled clay films with a platelet–void multilayered nanostructure and flame-blocking properties. Sci. Rep.3, 2621 (2013).
  • Slamova R , TrckovaM, VondruskovaH, ZralyZ, PavlikI. Clay minerals in animal nutrition. Appl. Clay Sci.51, 395–398 (2011).
  • Parolo ME , FernándezLG, ZajonkovskyI, SánchezMP, BaschiniM. Science against microbial pathogens: communicating current research and technological advances. In: Antibacterial Activity of Materials Synthesized from Clay Minerals. VilasAM ( Ed.). FORMATEX, 144–151 (2011). http://www.formatex.info/microbiology3/book/144–151.pdf.
  • Viseras C , AguzziC, CerezoP, Lopez-GalindoA. Uses fo clay minerals in semisolid health care and therapeutic products. Appl. Clay Sci.36, 37–50 (2007).
  • Wu Q , LiZ, HongH, WTR. Desorption of ciprofloxacin from clay mineral surfaces. Water Res.47, 259–268 (2013).
  • Das G , KalitaRD, GogoiP, BuragohainAK, KarakN. Antibacterial activities of copper nanoparticle-decorated organically modified montmorillonite/epoxy nanocomposites. Appl. Clay Sci.90, 18–26 (2014).
  • Bergaya F , LagalyG ( Eds). General Introduction: Clays, Clay Minerals, and Clay Science. In: Handbook of Clay Science (Volume 1). ThengBKG. Elsevier, Amsterdam, The Netherlands, 1–19 (2006).
  • Robert M F , ElsassF, HardyM. Crystallochemistry, Properties and Organization of Soil Clays Derived from Major Sedimentary Rocks in France. Clay Minerals26, 409–420 (1991).
  • Carretero MI , GomesCSF, TateoF. Clays and Human Health. In: Handbook of Clay Science (Volume 1).BergayaF, ThengBKG, LagalyG ( Eds). Elsevier, 717 (2006).
  • Murray HH . Traditional and new applications for kaolin, smectite, and palygorskite: a general overview. Appl. Clay Sci.17, 207–221 (2000).
  • Arab S , AlshikhA. The use of Clay Minerals of the Dead Sea as Drugs. In: Clay Minerals (Volume 5). MurrayHH ( Ed), NY, USA5, 112–115 (2012).
  • Silva PSC , OliveiraSMB, FariasL, FávaroDIT, MazzilliBP. Chemical and radiological characterization of clay minerals used in pharmaceutics and cosmetics. Appl. Clay Sci.52, 145–149 (2011).
  • Carretero MI , PozoM. Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients. Appl. Clay Sci.47, 171–181 (2010).
  • Williams LB , HaydelSE. Evaluation of the medicinal use of clay minerals as antibacterial agents. Int. Geol. Rev.52, 745–770 (2010).
  • Maheshwari RK , SharmaSN, JainNK. Adsorption studies of phenformin hydrochloride on some clays and its application in formulating sustained release dosage forms. Ind. J. Pharm. Sci.50, 101–105 (1988).
  • Forni F , IannuccelliV, CameroniR, CoppiG, BernabeiMT. Swellable heterogeneous matrixes: physical properties and release mechanisms. Farmaco Prat.41, 155–164 (1986).
  • Forni F , IannuccelliV, CoppiG, BernabeiMT. Effect of montmorillonite on drug release from polymeric matrices. Arch. Pharm.322, 789–793 (1989).
  • Aguzzi C , ViserasC, CerezoP, RossiS, FerrariF, CaramellaC. Control of tetracyclines delivery by their interaction with veegum. In: Proceedingsa of the 30th Annual Meeting & Exposition of the Controlled Release Society. 19–23 July (Glasgow, Scotland, UK (2003). Abstract 730).
  • Aguzzi C , ViserasC, CruzJ, ZafraM, CerezoP, RossiS. Development of new controlled release systems based on mineral supports: III. Release studies of tetracyclines–silicate interaction products. Proceedings Of The 1st Eufeps Conference On Optimising Drug Delivery And Formulation: New Challenges In Drug Delivery. Acta del Congreso, Versailles, 136–137 (2003).
  • Cerezo P . Mecanismos Y Cineticas De Adsorcion-Liberacion De Farmacos En Soportearcilloso. Contribución Al Estudio De Complejostimololmaleato Con Esmectitas, Paligorskitas Y Sepiolitas. University of Granada, Granada (E), [PhD thesis] (2003).
  • Ambrogi V , FardellaG, GrandoliniG, PerioliL. Intercalation compounds of hydrotalcite-like anionic clays with antinflammatory agents. I. Intercalation and in release of ibuprofen. Int. J. Pharm.220, 23–32 (2001).
  • Ambrogi V , FardellaG, GrandoliniG, PerioliL, TiraltiMC. Intercalation compounds of hydrotalcite-like anionic clays with antinflammatory agents. II. Uptake of diclofenac for a controlled release formulation. AAPS PharmSci Tech.3, E26 (2002).
  • Rodrigues LA A , VeigaF, de FreitasRMet al. The systems containing clays and clay minerals from modified drug release: a review. Colloids Surf. B Biointerfaces103, 642–651 (2013).
  • Shrivastava R , JainSR, FrankSG. Dissolution dialysis studies of metronidazole–montmorilloniteadsorbates. J. Pharm. Sci.74, 214–216 (1985).
  • Lin FH , LeeYH, JianCH. A study of purified montmorillonite intercalated with 5-fluorouracile as drug carrier. Biomaterials23, 1981–1987 (2002).
  • Aguzzi C , FerrariF, GattiA, RossiS, BonferoniMC, CerezoP. Novel controlled release formulations based on tetracycline–clay interaction products for periodontal administration. Proceedings of the 45th Simposio AFI. Rimini Italy (2005). 177.
  • Aguzzi C , FerrariF, CerezoP, RossiS, BonferoniMC, DacarroC. Suitability assessment of tetracycline-loaded clays in the treatment of periodontitis. Proceedings of the 1stPharmSciFair, Pharmaceutical Sciences Fair and Exhibition. NICE, France PO-258 (2005).
  • Wai KN , BankerGS. Some physicochemical properties of the montmorillonites. J. Pharm. Sci.55, 1215–1220 (1966).
  • Fielden KE . US5556639 (1996).
  • Viseras MT , AguzziC, CerezoP, ViserasC, Lopez-GalindoA, ValenzuelaC. Study of adsorption kinetics of 5-aminosalicilyc acid in phyllosilicates for controlled drug delivery in the treatment of inflammatory bowel disease. Pharmaceutical Sciences Fair and Exhibition.Nice, France, PO-253 (2005).
  • Zhu Y , AdjeiAL. US2002110527 (2002).
  • Price RR , GaberBP, LvovY. In vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dinucleotide from halloysite; a cylindrical mineral. J. Microencapsul.18, 713–722 (2001).
  • Byrne R S , DeasyPB. Use of porous aluminosilicate pellets for drug delivery. J. Microencapsulation.22, 423–437 (2005).
  • Levis SR , DeasyPB. Use of coated microtubular halloysite for the sustained release of hydrochloride and propranolol hydrochloride. Int. J. Pharm.253, 145–157 (2003).
  • Lopez-Galindo A , ViserasC, CerezoP. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Appl. Clay Sci.36, 51–63 (2007).
  • Arco MD , FernándezA, MartínC, RivesV. Release studies of different NSAIDs encapsulated in Mg,Al,Fe-hydrotalcites. App. Clay Sci.42, 538–544 (2009).
  • Choy JH , ChoiSJ, OhJM, ParkT. Clay minerals and layered double hydroxides for novel biological applications. Appl. Clay Sci.36, 122–132 (2007).
  • Sironmani TA . Comparison of nanocarriers for gene delivery and nanosensing using montmorillonite, silver nanoparticles and multiwalled carbon nanotubes. Appl. Clay Sci.103, 55–61 (2015).
  • Liu P . Polymer modified clay minerals: A review. Appl. Clay Sci.38, 64–76 (2007).
  • Guggenheim S , AdamsJM, BainDCet al. Summary of recommendations of nomenclature committees relevant to clay mineralogy: report of the Association Internationale pour l'Etude des Argiles (AIPEA) Nomenclature Committee for 2006. Clay Minerals41, 863–877 (2006).
  • Chiu C , HuangT, WangY, AlamaniB, LinJJ. Intercalation strategies in clay/polymer hybrids. Progr. Polymer Sci.39(3), 443–485 (2014).
  • Sposito G , SkipperNT, SuttonR, ParkSH, SoperAK, GreathouseJA. Surface geochemistry of the clay minerals. Proc. Natl Acad. Sci. USA96, 3358–3364 (1999).